ATE504592T1 - Trehaloseverbindung und arzneimittel mit der verbindung - Google Patents

Trehaloseverbindung und arzneimittel mit der verbindung

Info

Publication number
ATE504592T1
ATE504592T1 AT07739277T AT07739277T ATE504592T1 AT E504592 T1 ATE504592 T1 AT E504592T1 AT 07739277 T AT07739277 T AT 07739277T AT 07739277 T AT07739277 T AT 07739277T AT E504592 T1 ATE504592 T1 AT E504592T1
Authority
AT
Austria
Prior art keywords
compound
trehalose
present
drugs containing
independently represent
Prior art date
Application number
AT07739277T
Other languages
English (en)
Inventor
Mugio Nishizawa
Hiroshi Imagawa
Hirofumi Yamamoto
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Application granted granted Critical
Publication of ATE504592T1 publication Critical patent/ATE504592T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT07739277T 2006-03-27 2007-03-22 Trehaloseverbindung und arzneimittel mit der verbindung ATE504592T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006085245 2006-03-27
PCT/JP2007/055834 WO2007111214A1 (ja) 2006-03-27 2007-03-22 トレハロース化合物および該化合物を含有する医薬

Publications (1)

Publication Number Publication Date
ATE504592T1 true ATE504592T1 (de) 2011-04-15

Family

ID=38541134

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07739277T ATE504592T1 (de) 2006-03-27 2007-03-22 Trehaloseverbindung und arzneimittel mit der verbindung

Country Status (12)

Country Link
US (1) US8163713B2 (de)
EP (1) EP2000473B1 (de)
JP (1) JP5114627B2 (de)
KR (1) KR101412082B1 (de)
CN (1) CN101443344B (de)
AT (1) ATE504592T1 (de)
DE (1) DE602007013730D1 (de)
DK (1) DK2000473T3 (de)
ES (1) ES2362940T3 (de)
PT (1) PT2000473E (de)
TW (1) TWI382989B (de)
WO (1) WO2007111214A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5258582B2 (ja) * 2007-01-31 2013-08-07 株式会社糖鎖工学研究所 トレハロース化合物、その製造方法、及び該化合物を含有する免疫賦活剤
CN102203110A (zh) * 2008-10-31 2011-09-28 大塚化学株式会社 海藻糖化合物、其制造方法以及含有该化合物的药品
TW201242932A (en) * 2011-03-08 2012-11-01 Abbott Lab Process for the preparation of 1,2,4-oxadiazol-3-yl derivatives of carboxylic acid
JPWO2012147705A1 (ja) * 2011-04-24 2014-07-28 株式会社ネクスト２１ トレハロースを含有する炎症性呼吸器疾患の治療剤
US10493023B2 (en) 2013-05-07 2019-12-03 Seelos Therapeutics, Inc. Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
WO2019197595A2 (en) 2018-04-13 2019-10-17 Glaxosmithkline Biologicals Sa Compounds and uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006514A (en) * 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
US5049664A (en) 1988-08-26 1991-09-17 Sawai Pharmaceutical Co., Ltd. Trehalose derivatives
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
JPH11158073A (ja) 1997-09-26 1999-06-15 Takeda Chem Ind Ltd アデノシンａ３拮抗剤
JPH11171727A (ja) * 1997-09-30 1999-06-29 Kanebo Ltd 身体洗浄剤組成物
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US6686366B1 (en) * 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
JP2003519102A (ja) 1999-12-02 2003-06-17 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド アデノシンａ▲下１▼、ａ▲下２ａ▼およびａ▲下３▼受容体に対して特異的な化合物並びにその使用
EP1469864A1 (de) 2002-01-25 2004-10-27 Muscagen Limited Verbindungen verwendbar als adenosin-a3-rezeptor-agoniste
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
AU2004254999A1 (en) * 2003-06-27 2005-01-13 Generate, Inc. Method of and system for determining connections between parties using private links

Also Published As

Publication number Publication date
EP2000473A2 (de) 2008-12-10
DK2000473T3 (da) 2011-05-16
DE602007013730D1 (de) 2011-05-19
CN101443344A (zh) 2009-05-27
EP2000473B1 (de) 2011-04-06
US8163713B2 (en) 2012-04-24
JPWO2007111214A1 (ja) 2009-08-13
ES2362940T3 (es) 2011-07-15
US20100249057A1 (en) 2010-09-30
WO2007111214A1 (ja) 2007-10-04
EP2000473A9 (de) 2009-03-25
PT2000473E (pt) 2011-07-01
TWI382989B (zh) 2013-01-21
KR101412082B1 (ko) 2014-06-26
JP5114627B2 (ja) 2013-01-09
CN101443344B (zh) 2012-08-29
TW200745153A (en) 2007-12-16
KR20080103603A (ko) 2008-11-27
EP2000473A4 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
EP1775289A4 (de) Neue imidazolidinderivate
ATE504592T1 (de) Trehaloseverbindung und arzneimittel mit der verbindung
CA2532818A1 (en) (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
TW200745034A (en) New compounds
MY153045A (en) Oxopyrazine derivative and herbicide
WO2009072621A1 (ja) 置換ジヒドロアゾール化合物及び有害生物防除剤
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
TNSN07397A1 (en) Acetylene derivatives
EP1719761A4 (de) Neue heterocyclische verbindung
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
TW200626559A (en) Anilino-pyrimidine analogs
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
MX2009007482A (es) Agentes antiparasitarios.
BRPI0619894B8 (pt) composto de amina e composição farmacêutica
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
MX2010001566A (es) Derivado de aminopirazolamida.
NZ596653A (en) Total synthesis of salinosporamide a and analogs thereof
DE602008005238D1 (de) Bisphenol Monoester
MX2009012471A (es) Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6.
MY183326A (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
SG154418A1 (en) Granular composition and production thereof
MX2009004006A (es) Derivados de indol novedosos, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
ATE519818T1 (de) Reversibel thermochrome zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2000473

Country of ref document: EP